With the greater success of liver transplantation, livers from deceased donors are insufficient to meet the need for livers required for transplantation. In various parts of Asia, living related liver transplantation is the treatment for patients with end-stage liver disease. An overview of anaesthesia for both the donor and the recipient is described. Controversies involving epidural anaesthesia, blood loss prevention and blood conservation techniques in the donor are discussed. Various aspects in the anaesthetic management of the recipient are also looked at.
TakadaYSuzukamoYOikeFEgawaHMoritaSFukuharaS. Long-term quality of life of donors after living donor liver transplantation. Liver Transpl2012 Jul 20. doi: 10.1002/lt.23509. [Epub ahead of print].
2.
LeeJPKwonHYParkJIYiNJSuhKSLeeHW. Clinical outcomes in patients with hepatorenal syndrome after living-donor liver transplantation. Liver Transpl2012 Jun 19. doi: 10.1002/lt.23493. [Epub ahead of print].
3.
O'LearyJGLepeRDavisGL. Indications for Liver Transplantation. Gastroenterology2008 May;134(6):1746–76.
4.
MarcosAFisherRAHamJMShiffmanMLSanyalAJLuketicVAC. Right lobe living donor transplantation. Transplantation1999;68:798–803.
5.
ChhibberADziakJKolanoJNortonJRLustikS. Anaesthesia care for adult live donor hepatectomy: Our experience with 100 cases. Liver Transpl2007 Apr;13(4):537–42.
6.
BuggyDJSmithG. Epidural anaesthesia and analgesia: Better outcome after major surgery? Growing evidence suggest so. BMJ1999;319(7209):530–1.
7.
KehletHHolteK. Effect of postoperative analgesia on surgical outcome. Br J Anaesth2001;87(1):62–7.
8.
SiniscalchiABegiominiBDe PietriLBragliaVGazziMMasettiM. Increased prothrombin time and platelet counts in living donor right hepatectomy: Implications for epidural anesthesia. Liver Transpl2004 Sept;10(9): 1144–9.
9.
StamenkovicDMJankovicZBToogoodGJLodgeJPBellamyMC. Epidural analgesia and liver resection: Postoperative coagulation disorders and epidural catheter removal. Minerva Anestesiol2011 Jul;77(7): 671–9.
10.
WheatleyRGSchugSAWatsonD. Safety and efficacy of postoperative epidural analgesia. Br J Anaesth2001;87:47–61.
11.
ChoiSJGwakMSKoJSKimGSAhnHJYangM. The changes in coagulation profile and epidural catheter safety for living donors: A report on 6 years of our experience. Liver Transpl2007 Jan;13(1):62–70.
12.
RudinALundbergJFHammarlund-UdenaesMFlisbergPWernerMU. Morphine metabolism after major liver surgery. Anesth Analg2007;104:1409–14.
13.
SmileyRMOrnsteinEPantuckEJPantuckCBMarteoRS. Metabolism of desflurane and isoflurane to fluoride ion in surgical patients. Can J Anaesth1991;38(8):965–8.
14.
O'RiordanJO'BieirneHAYoungYBellamyMC. Effects of desflurane and isoflurane on splanchnic microcirculation during major surgery. Br J Anaesth1997;78(1):95–6.
15.
KoJSKimGShinYHGwakMSKimGSKwonCH. The effects of desflurane and isoflurane on hepatic and renal functions after right hepatectomy in living donors. Transplant Proc2012 Mar;44(2):442–4.
16.
ToprakHISahinTAsianSKarahanKSanliMErsoyMO. Effects of desflurane and isoflurane on hepatic and renal functions and coagulation profile during donor hepatectomy. Transplantation Proc2012 Jul;44(6): 1635–9.
17.
JonesRMMoultonCEHardyKJ. Central venous pressure and its effects on blood loss during liver resection. Br J Surg1996;83(11):1562–9.
18.
MelendezJAArslanVFisherMEWuestDJarnaginWRFongY. Perioperative outcomes of major hepatic resections under low central venous pressure anaesthesia: Blood loss, blood transfusion and the risk of postoperative renal dysfunction. J Am Coll Surg1998;187(6):620–5.
19.
ChenCLChenYSde VillaVHWangCCLinCLGotoS. Minimal blood loss living donor hepatectomy. Transplantation2000;69:2580–6.
20.
FeltraccoPBrezziMLBarbieriSSerraEMilevojMOriC. Epidural anesthesia and analgesia in liver resection and living donor hepatectomy. Transplant Proc2008;40: 1165–8.
21.
LutzJTGamazoVCGorlingerKMalagoMPetersJ. Blood transfusion requirements and blood salvage in donors undergoing right hepatectomy for living related liver transplantation. Anesth Analg2003;96:351–5.
22.
HorlockerTWedelDJRowlingsonJCEnnekingFKKoppSLBenzonHT. Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med2010;35:64–101.
23.
CeruttiEStrattaCRomagnoliRSchellinoMMSkurzakSRizzettoM. Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation. Liver Transpl2004 Feb; 10(2):289–94.
24.
StravitzRTLismanTLuketicVASterlingRKPuriPFuchsM. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by TSG. J Hepatol2012 Jan;56(1):129–36.
25.
RamsayMASimpsonBRNguyenATRamsayKJEastCKlintmalmGB. Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg1997 Sept;3(5):494–500.
26.
HoeperMMKrowlaMJStrassburgCP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet2004;363:1461–8.
27.
SafdarZBartolomeSSussmanN. Portopulmonary Hypertension: An Update. Liver Transpl2012 Aug;18(8):881–91.
28.
YassenAMElsarrafWRElsadanyMElshobariMMSalahTSultanAM. The impact of portopulmonary hypertension on intraoperative right ventricular function of living donor liver transplant recipients. Anesth Analg2012;115:683–93.
29.
MachicaoVIFallonMB. Hepatopulmonary syndrome. Semin Respir Crit Care Med2012 Feb;33(1):11–6.
30.
SalernoFGerbesAGinesPWongFArroyoV. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut2007;56(9):1310–18.
31.
FagundesCGinesP. Hepatorenal syndrome: A severe, but treatable, cause of kidney failure in cirrhosis. Am J Kidney Dis2012 Jun;59(6):874–85.
32.
AdachiT. Anesthetic principles in living-donor liver transplantation at Kyoto University Hospital: Experiences of 760 cases. J Anesth2003;17:116–24.
33.
GwakMSKimJAKimGSChoiSJAhnHLeeJJ. Incidence of severe ventricular arrhythmias during pulmonary artery catheterization in liver allograft recipients. Liver Transpl2007 Oct;13:1451–4.
34.
BurtenshawAJIsaacJL. The role of trans-oesophageal echocardiography for perioperative cardiovascular monitoring during orthotopic liver transplantation. Liver Transpl2006 Nov;12:1577–83.
35.
SpierBJLarueSJTeelinTCLeffJASwizeLRBorkanSH. Review of complications in a series of patients with known gastro-esophageal varices undergoing transesophageal echocardiography. J Am Soc Echocardiogr2009;22:401–3.
36.
TsaiYFSuBCLinCCLiuFCLeeWCYuHP. Cardiac output derived from arterial pressure waveform analysis: Validation of the third generation software in patients undergoing orthotopic liver transplantation. Transplant Proc2012 Mar;44(2):433–7.
37.
SuBCTsaiYFChenCYYuHPYangMWLeeWC. Cardiac output derived from arterial pressure waveform analysis in patients undergoing liver transplantation: Validity of a third-generation device. Transplant Proc2012 Mar;44(2):424–8.
38.
MassicotteLSassineMPLenisSRoyA. Transfusion Predictors in Liver Transplant. Anesth Analg2004 May;98:1245–51.
39.
MassicotteLLenisSThibeaultLSassineMPSealRFRoyA. Effect of low central venous pressure and phlebotomy on blood transfusion requirements during liver transplantation. Liver Transpl2006 Jan;12(1):117–23.
40.
PorteRJMolenaarIQBegliominiBGroenlandTHJanuszkiewiczALingrenL. Aprotinin and transfusion requirements in orthotopic liver transplantation: A multicentre randomized double-blind study. Lancet2000 Apr 15;355(9212):1303–9.
41.
DalmauASabateAAcostaFGarcia-HueteLKooMSansanoT. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesth Analg2000 Jul;91(1):29–34.
42.
DalmauASabateAKooMBartolomeCRafecasAFiguerasJ. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: A comparative study. Liver Transpl2004 Feb;10(2):279–84.
43.
FitzsimonsMGPeterfreundRARainesDE. Aprotinin administration and pulmonary thromboembolism during orthotopic liver transplantation: Report of two cases. Anesth Analg2001 Jun;92(6):1418–21.
44.
RamsayMRandallH. Intravascular thrombosis and thromboembolism during liver transplantation: Antifibrinolytic therapy implicated?Liver Transpl2004 Feb;10(2):310–4.
45.
HartogCSBauerMReinhartK. The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg2011 Jan;112(1):156–64.
46.
BayerOReinhartKKohlMKabischBMarshallJSakrY. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: A prospective sequential analysis. Crit Care Med2012 Sep;40(9):2543–51.
47.
MassicotteLSassineMPLenisSSealRFRoyA. Survival rate changes with transfusion of blood products during liver transplantation. Can J Anaesth2005 Feb;52(2): 148–55.
48.
PereboomITde BoerMTHaagsmaEBHendriksHGLismanTPorteRJ. Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg2009 Apr;108(4):1083–91.
49.
AggarwalSKangYFreemanJAFortunatoFLPinskyMR. Postreperfusion syndrome: Cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc1987 Aug;19 (4Suppl 3):54–5.
50.
Paugam-BurtzCKavafyanJMerckxPDahmaniSSommacaleDRamsayM. Postreperfusion syndrome during liver transplantation for cirrhosis: Outcome and predictors. Liver Transpl2009 May;15(5):522–9.
51.
XuZDXuHTYuanHBZhangHJiRHZouZ. Postreperfusion syndrome during orthotopic liver transplantation: A single center experience. Hepatobiliary Pancreat Dis Int2012 Feb;11(1):34–9.
